Silk Road forums

Market => Product offers => Topic started by: cowpie34 on February 11, 2013, 10:03 pm

Title: 1,4 Butandiol SAME as GHB shipping from US - Half price of competition same thin
Post by: cowpie34 on February 11, 2013, 10:03 pm
here's my listings and some info   http://silkroadvb5piz3r.onion/silkroad/user/edbcc8a90a


SAME AS GHB; BECOMES GHB IN 15 MINUTES IN YOUR BRAIN.
about 250 doses
WHY PAY $700+ for 500 grams GHB when this is as just much for $400. 1 Gram GHB POWDER = 1ml 1,4 Butanediol
Read below about 1,4 Butanediol being non-carcinogenic
Free overnight
Read below about 1,4 Butanediol being non-carcinogenic; safe for consumption

1,4 Butanediol takes 15 min to be converted to GHB inside your body. People say 2.5ml is a good strong dose but I have seen several people need to start as low as 1.5ml. It's strong stuff and A LOT of fun!! Mine is the highest grade. It's reported to be more pleasurable than GHB, but it is the EXACT same thing though with a 15 minute delay. Why would you pay insane GHB or GBL prices when this is the exact same thing and much much cheaper? Believe I have been doing G for a long time and there is NO difference.

Any questions please ask. Par the rules as I'm a new seller you may stay in escrow. Because of this I may only be able to fill a limited amount of orders at first, and then when once I start building capital things will resume and the spice will flow~~

I will not ship to Italy, Spain, France, Africa, or South America (Brazil)

Summary of Key Health Issues
The toxicity of 1,4-butanediol appears to be restricted to acute toxicity and slight skin, eye and respiratory
tract irritation. From repeated dose studies, it is evident that the most sensitive adverse effect is neurotoxicity.
Overall, the short duration and nature of the available studies do not allow for the identification of a
robust dose-response and No-Observed-Adverse-Effect-Level (NOAEL). There are no data to indicate that
1,4-butanediol is a skin sensitiser, genotoxic, carcinogenic, or a reproductive toxicant.

As documented in the scientific literature, 1,4-butanediol is rapidly absorbed and metabolized to -hydroxybutyric acid in animals and humans. A metabolism and disposition study conducted in F344/N rats
14 14
by the NTP confirmed the rapid and extensive conversion of 1-[ C]-1,4-butanediol to CO . 2 Because of this rapid and extensive conversion, the toxicological profile of 1,4-butanediol reflects that of -hydroxybutyric acid. -Hydroxybutyric acid is a naturally occurring chemical found in the brain and peripheral tissues which is converted to succinate and processed through the tricarboxylic acid cycle. Although the function of -hydroxybutyric acid in peripheral tissues is unknown, in the brain and neuronal tissue it is thought to function as a neuromodulator. -Hydroxybutyric acid readily crosses the blood-brain barrier, and oral, intraperitoneal, or intravenous administration elicits characteristic neuropharmacologic responses. These same responses are observed after administration of 1,4-butanediol.
The lactone of -hydroxybutyric acid, -butyrolactone, is also rapidly converted to -hydroxybutyric acid by enzymes in the blood and liver of animals and humans. -Butyrolactone was previously evaluated by the NTP in 14-day and 13-week toxicology studies and 2-year toxicology and carcinogenesis studies in F344/N rats and B6C3F mice. No organ-specific toxicity occurred in the toxicology studies. In the carcinogenesis
1
studies, an equivocal response occurred in male mice, based on a marginal increase in the
6 1,4-Butanediol, NTP TOX 54
incidence of pheochromocytomas of the renal medulla. Because of the rapid and extensive conversion of -butyrolactone to -hydroxybutyric acid, the evaluation of -butyrolactone was in fact an evaluation of -hydroxybutyric acid.
This summary report presents a review of the current literature which documents that both 1,4-butanediol and -butyrolactone are rapidly metabolized to
-hydroxybutyric
acid, and the pharmacologic and toxicologic responses to these chemicals are due to their metabolic conversion to
-hydroxybutyric
acid. Because the toxicity and carcinogenicity of -hydroxybutyric acid was fully evaluated in the NTP studies of -butyrolactone, and a lack of organ-specific toxicity or carcinogenic potential was demonstrated, it is concluded that there is a high likelihood that 1,4-butanediol would be negative in a similar set of studies. For these reasons, it is the opinion of the NTP that 1,4-butanediol should be considered not carcinogenic in animals and no further evaluation of 1,4-butanediol is needed at this time.